341 – 350 of 540
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Influence on the Health of the Partner Affected by Tumor Disease in the Wife or Husband Based on a Population-Based Register Study of Cancer in Sweden.
(
- Contribution to journal › Article
-
Mark
Translocation-related sarcomas.
(
- Contribution to journal › Article
-
Mark
Lifelong Cancer Incidence in 47 697 Patients Treated for Childhood Cancer in the Nordic Countries.
(
- Contribution to journal › Article
-
Mark
Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer - A randomized trial from the South Sweden Breast Cancer Group.
(
- Contribution to journal › Article
-
Mark
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study.
(
- Contribution to journal › Article
-
Mark
A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk.
(
- Contribution to journal › Article
-
Mark
Dose-dense induction followed by autologous stem cell transplant (ASCT) leads to sustained remissions in a large fraction of patients with previously untreated peripheral t-cell lymphomas (PTCLS) - overall and subtype-specific results of a phase II study from the nordic lymphoma group
2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.1082-1082(
- Contribution to journal › Published meeting abstract
-
Mark
Selection criteria for genetic assessment of patients with familial melanoma
(
- Contribution to journal › Scientific review
-
Mark
Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis
(
- Contribution to journal › Article
- 2008
-
Mark
R-CHOEP-14 X 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18-64 Years.
(
- Contribution to journal › Published meeting abstract